Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2020 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Oncology and Cardiac Rehabilitation: An Underrated Relationship.
Venturini E, Iannuzzo G, D'Andrea A, Pacileo M, Tarantini L, Canale ML, Gentile M, Vitale G, Sarullo FM, Vastarella R, Di Lorenzo A, Testa C, Parlato A, Vigorito C, Giallauria F. Venturini E, et al. J Clin Med. 2020 Jun 10;9(6):1810. doi: 10.3390/jcm9061810. J Clin Med. 2020. PMID: 32532011 Free PMC article. Review.
The core components of cardio-oncology rehabilitation.
Venturini E, Gilchrist S, Corsi E, DI Lorenzo A, Cuomo G, D'Ambrosio G, Pacileo M, D'Andrea A, Canale ML, Iannuzzo G, Sarullo FM, Vigorito C, Barni S, Giallauria F. Venturini E, et al. Panminerva Med. 2021 Jun;63(2):170-183. doi: 10.23736/S0031-0808.21.04303-2. Epub 2021 Feb 2. Panminerva Med. 2021. PMID: 33528152
Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology.
Quagliariello V, Passariello M, Bisceglia I, Paccone A, Inno A, Maurea C, Rapuano Lembo R, Manna L, Iovine M, Canale ML, Scherillo M, Ascierto PA, Gabrielli D, De Lorenzo C, Maurea N. Quagliariello V, et al. Front Cardiovasc Med. 2024 Jan 23;11:1232269. doi: 10.3389/fcvm.2024.1232269. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38322766 Free PMC article.
Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, Maurea N. Quagliariello V, et al. Front Cardiovasc Med. 2022 Sep 8;9:930797. doi: 10.3389/fcvm.2022.930797. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36158826 Free PMC article.
Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.
Quagliariello V, Passariello M, Di Mauro A, Cipullo C, Paccone A, Barbieri A, Palma G, Luciano A, Buccolo S, Bisceglia I, Canale ML, Gallucci G, Inno A, De Lorenzo C, Maurea N. Quagliariello V, et al. Front Cardiovasc Med. 2023 Jan 19;10:1129873. doi: 10.3389/fcvm.2023.1129873. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 36742077 Free PMC article.